Kolexia
Grando-Lemaire Veronique Gastro-entérologie
Grando-Lemaire Veronique
Gastro-entérologie
Hôpital Avicenne
Bobigny, France
55 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinome hépatocellulaire Carcinomes Tumeurs du foie Fibrose Cirrhose du foie Hépatite Hépatite C chronique Hépatite C Hépatite B

Collaborateurs

Voir plus
Carrie Nathalie
Carrie Nathalie
Hôpital Jean Verdier, Bondy, France
Nkontchou-Morel Gisele
Nkontchou-Morel Gisele
Hôpital Jean Verdier, Bondy, France
Nahon Pierre
Nahon Pierre
Hôpital Jean Verdier, Bondy, France
Ziol Marianne
Ziol Marianne
Hôpital Avicenne, Bobigny, France

Industries

Voir plus
Abbvie
5 collaboration(s)
Dernière en 2023
Gilead
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2021
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
Liver international : official journal of the International Association for the Study of the Liver   04 mars 2024
Activity of Tepotinib in Hepatocellular Carcinoma With High-Level Amplification: Preclinical and Clinical Evidence.
JCO precision oncology   16 février 2024
Imaging and histological features of tumor biopsy sample predict aggressive intrasegmental recurrence of hepatocellular carcinoma after radiofrequency ablation.
Scientific reports   04 novembre 2022
c-Met Second-Line Hepatocellular Carcinoma: A Multicenter, Single Arm, Phase Ib/II Study to Evaluate Efficacy, Safety, and PK of MSC2156119J as Monotherapy in Subjects With MET+ Advanced Hepatocellular Carcinoma With Child Pugh Class A Liver Function Who Have Failed Sorafenib Treatment
Essai Clinique (Merck KGaA)   22 août 2022
Correction: Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
British journal of cancer   20 août 2021
Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion.
Clinics and research in hepatology and gastroenterology   15 juin 2021
Phase 1b/2 trial of tepotinib in sorafenib pretreated advanced hepatocellular carcinoma with MET overexpression.
British journal of cancer   06 avril 2021
Activity of tepotinib in hepatocellular carcinoma (HCC) with high-level MET amplification (METamp): Preclinical and clinical evidence.
2021 Gastrointestinal Cancers Symposium   22 janvier 2021
Prior surveillance and antiviral treatment improve the prognosis of HCC developed in HBV patients in the West.
Clinics and research in hepatology and gastroenterology   14 mai 2020
Hepatocellular Carcinoma within Milan Criteria: No-Touch Multibipolar Radiofrequency Ablation for Treatment-Long-term Results.
Radiology   20 novembre 2019